{"id":4221,"date":"2015-12-01T17:41:44","date_gmt":"2015-12-01T16:41:44","guid":{"rendered":"https:\/\/genepredictis.com\/?p=4221"},"modified":"2023-02-01T10:49:07","modified_gmt":"2023-02-01T09:49:07","slug":"gene-predictis-closes-its-first-financing-round","status":"publish","type":"post","link":"https:\/\/genepredictis.com\/fr\/gene-predictis-closes-its-first-financing-round\/","title":{"rendered":"Gene Predictis\u00ae cl\u00f4t son premier cycle de financement"},"content":{"rendered":"<p>Gene Predictis<sup>\u00ae<\/sup>, une soci\u00e9t\u00e9 suisse de m\u00e9decine de pr\u00e9cision, annonce la cl\u00f4ture de son premier tour de financement. La soci\u00e9t\u00e9 a lev\u00e9 0,5 million de francs suisses aupr\u00e8s d&rsquo;un investisseur strat\u00e9gique qui est un acteur majeur de l&rsquo;\u00e9cosyst\u00e8me suisse de la sant\u00e9. Le produit de la lev\u00e9e de fonds sera utilis\u00e9 pour soutenir le marketing et la commercialisation en Suisse de son produit phare, Pill Protect<sup>\u00ae<\/sup>, ainsi que pour l&rsquo;\u00e9tiquetage CE-IVD de Pill Protect<sup>\u00ae<\/sup>\u00a0afin de garantir son lancement en temps voulu sur le march\u00e9 europ\u00e9en. Prot\u00e9ger la pilule<sup>\u00ae<\/sup>\u00a0est un test m\u00e9dical innovant qui utilise des donn\u00e9es g\u00e9n\u00e9tiques pour identifier les femmes \u00e0 risque de d\u00e9velopper des caillots sanguins (thrombose) lors de l&rsquo;utilisation de pilules contraceptives. Le test a \u00e9t\u00e9 lanc\u00e9 en Suisse \u00e0 la mi-septembre 2015 et a re\u00e7u une premi\u00e8re acceptation tr\u00e8s prometteuse sur le march\u00e9. La cl\u00f4ture de cet investissement initial fait suite \u00e0 l&rsquo;atteinte d&rsquo;une s\u00e9rie d&rsquo;\u00e9tapes importantes en 2015, notamment la r\u00e9ussite de l&rsquo;\u00e9tude de validation clinique de Pill Protect.<sup>\u00ae<\/sup>, Pill Protect<sup>\u00ae\u00a0<\/sup>le d\u00e9p\u00f4t du brevet et le lancement du produit sur le march\u00e9 suisse. Gene Predictis<sup>\u00ae<\/sup>\u00a0poursuit un investissement suppl\u00e9mentaire avec un partenaire financier principalement pour financer le lancement de Pill Protect<sup>\u00ae<\/sup>\u00a0et Cypass<sup>\u00ae<\/sup>, un autre produit strat\u00e9gique, sur les march\u00e9s ext\u00e9rieurs \u00e0 la Suisse. <a href=\"https:\/\/genepredictis.com\/wp-content\/uploads\/2022\/10\/announcement-financing.pdf\" target=\"_blank\" rel=\"noopener\">annonce de financement<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Gene Predictis\u00ae, une soci\u00e9t\u00e9 suisse de m\u00e9decine de pr\u00e9cision, annonce la cl\u00f4ture de son premier tour de financement. La soci\u00e9t\u00e9 a lev\u00e9 0,5 million de francs suisses aupr\u00e8s d&rsquo;un investisseur strat\u00e9gique qui est un acteur majeur de l&rsquo;\u00e9cosyst\u00e8me suisse de la sant\u00e9. Le produit de la lev\u00e9e de fonds sera utilis\u00e9 pour soutenir le marketing [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[30],"tags":[],"class_list":["post-4221","post","type-post","status-publish","format-standard","hentry","category-nouvelles"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Gene Predictis - Beacuse I am unique<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/genepredictis.com\/fr\/gene-predictis-closes-its-first-financing-round\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gene Predictis - Beacuse I am unique\" \/>\n<meta property=\"og:description\" content=\"Gene Predictis\u00ae, une soci\u00e9t\u00e9 suisse de m\u00e9decine de pr\u00e9cision, annonce la cl\u00f4ture de son premier tour de financement. La soci\u00e9t\u00e9 a lev\u00e9 0,5 million de francs suisses aupr\u00e8s d&rsquo;un investisseur strat\u00e9gique qui est un acteur majeur de l&rsquo;\u00e9cosyst\u00e8me suisse de la sant\u00e9. Le produit de la lev\u00e9e de fonds sera utilis\u00e9 pour soutenir le marketing [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/genepredictis.com\/fr\/gene-predictis-closes-its-first-financing-round\/\" \/>\n<meta property=\"og:site_name\" content=\"Genepredictis\" \/>\n<meta property=\"article:published_time\" content=\"2015-12-01T16:41:44+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-02-01T09:49:07+00:00\" \/>\n<meta name=\"author\" content=\"masmo\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"masmo\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/genepredictis.com\\\/fr\\\/gene-predictis-closes-its-first-financing-round\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/genepredictis.com\\\/fr\\\/gene-predictis-closes-its-first-financing-round\\\/\"},\"author\":{\"name\":\"masmo\",\"@id\":\"https:\\\/\\\/genepredictis.com\\\/fr\\\/#\\\/schema\\\/person\\\/b71b43f714d8b16c629df67fbcc28171\"},\"headline\":\"Gene Predictis\u00ae cl\u00f4t son premier cycle de financement\",\"datePublished\":\"2015-12-01T16:41:44+00:00\",\"dateModified\":\"2023-02-01T09:49:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/genepredictis.com\\\/fr\\\/gene-predictis-closes-its-first-financing-round\\\/\"},\"wordCount\":249,\"publisher\":{\"@id\":\"https:\\\/\\\/genepredictis.com\\\/fr\\\/#organization\"},\"articleSection\":[\"Nouvelles\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/genepredictis.com\\\/fr\\\/gene-predictis-closes-its-first-financing-round\\\/\",\"url\":\"https:\\\/\\\/genepredictis.com\\\/fr\\\/gene-predictis-closes-its-first-financing-round\\\/\",\"name\":\"Gene Predictis - Beacuse I am unique\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/genepredictis.com\\\/fr\\\/#website\"},\"datePublished\":\"2015-12-01T16:41:44+00:00\",\"dateModified\":\"2023-02-01T09:49:07+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/genepredictis.com\\\/fr\\\/gene-predictis-closes-its-first-financing-round\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/genepredictis.com\\\/fr\\\/gene-predictis-closes-its-first-financing-round\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/genepredictis.com\\\/fr\\\/gene-predictis-closes-its-first-financing-round\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/genepredictis.com\\\/fr\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gene Predictis\u00ae cl\u00f4t son premier cycle de financement\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/genepredictis.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/genepredictis.com\\\/fr\\\/\",\"name\":\"Genepredictis\",\"description\":\"Because i am unique\",\"publisher\":{\"@id\":\"https:\\\/\\\/genepredictis.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/genepredictis.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/genepredictis.com\\\/fr\\\/#organization\",\"name\":\"Gene predictis\",\"url\":\"https:\\\/\\\/genepredictis.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/genepredictis.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/genepredictis.com\\\/wp-content\\\/uploads\\\/2021\\\/08\\\/logoNB.png\",\"contentUrl\":\"https:\\\/\\\/genepredictis.com\\\/wp-content\\\/uploads\\\/2021\\\/08\\\/logoNB.png\",\"width\":606,\"height\":170,\"caption\":\"Gene predictis\"},\"image\":{\"@id\":\"https:\\\/\\\/genepredictis.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/genepredictis.com\\\/fr\\\/#\\\/schema\\\/person\\\/b71b43f714d8b16c629df67fbcc28171\",\"name\":\"masmo\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/57bae57399cbed2da108452f7dd7e0b5394fa18315d8e0a8141267734d649b82?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/57bae57399cbed2da108452f7dd7e0b5394fa18315d8e0a8141267734d649b82?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/57bae57399cbed2da108452f7dd7e0b5394fa18315d8e0a8141267734d649b82?s=96&d=mm&r=g\",\"caption\":\"masmo\"},\"url\":\"https:\\\/\\\/genepredictis.com\\\/fr\\\/author\\\/masmo\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Gene Predictis - Beacuse I am unique","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/genepredictis.com\/fr\/gene-predictis-closes-its-first-financing-round\/","og_locale":"fr_FR","og_type":"article","og_title":"Gene Predictis - Beacuse I am unique","og_description":"Gene Predictis\u00ae, une soci\u00e9t\u00e9 suisse de m\u00e9decine de pr\u00e9cision, annonce la cl\u00f4ture de son premier tour de financement. La soci\u00e9t\u00e9 a lev\u00e9 0,5 million de francs suisses aupr\u00e8s d&rsquo;un investisseur strat\u00e9gique qui est un acteur majeur de l&rsquo;\u00e9cosyst\u00e8me suisse de la sant\u00e9. Le produit de la lev\u00e9e de fonds sera utilis\u00e9 pour soutenir le marketing [&hellip;]","og_url":"https:\/\/genepredictis.com\/fr\/gene-predictis-closes-its-first-financing-round\/","og_site_name":"Genepredictis","article_published_time":"2015-12-01T16:41:44+00:00","article_modified_time":"2023-02-01T09:49:07+00:00","author":"masmo","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"masmo","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/genepredictis.com\/fr\/gene-predictis-closes-its-first-financing-round\/#article","isPartOf":{"@id":"https:\/\/genepredictis.com\/fr\/gene-predictis-closes-its-first-financing-round\/"},"author":{"name":"masmo","@id":"https:\/\/genepredictis.com\/fr\/#\/schema\/person\/b71b43f714d8b16c629df67fbcc28171"},"headline":"Gene Predictis\u00ae cl\u00f4t son premier cycle de financement","datePublished":"2015-12-01T16:41:44+00:00","dateModified":"2023-02-01T09:49:07+00:00","mainEntityOfPage":{"@id":"https:\/\/genepredictis.com\/fr\/gene-predictis-closes-its-first-financing-round\/"},"wordCount":249,"publisher":{"@id":"https:\/\/genepredictis.com\/fr\/#organization"},"articleSection":["Nouvelles"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/genepredictis.com\/fr\/gene-predictis-closes-its-first-financing-round\/","url":"https:\/\/genepredictis.com\/fr\/gene-predictis-closes-its-first-financing-round\/","name":"Gene Predictis - Beacuse I am unique","isPartOf":{"@id":"https:\/\/genepredictis.com\/fr\/#website"},"datePublished":"2015-12-01T16:41:44+00:00","dateModified":"2023-02-01T09:49:07+00:00","breadcrumb":{"@id":"https:\/\/genepredictis.com\/fr\/gene-predictis-closes-its-first-financing-round\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/genepredictis.com\/fr\/gene-predictis-closes-its-first-financing-round\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/genepredictis.com\/fr\/gene-predictis-closes-its-first-financing-round\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/genepredictis.com\/fr\/home\/"},{"@type":"ListItem","position":2,"name":"Gene Predictis\u00ae cl\u00f4t son premier cycle de financement"}]},{"@type":"WebSite","@id":"https:\/\/genepredictis.com\/fr\/#website","url":"https:\/\/genepredictis.com\/fr\/","name":"Genepredictis","description":"Because i am unique","publisher":{"@id":"https:\/\/genepredictis.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/genepredictis.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/genepredictis.com\/fr\/#organization","name":"Gene predictis","url":"https:\/\/genepredictis.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/genepredictis.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/genepredictis.com\/wp-content\/uploads\/2021\/08\/logoNB.png","contentUrl":"https:\/\/genepredictis.com\/wp-content\/uploads\/2021\/08\/logoNB.png","width":606,"height":170,"caption":"Gene predictis"},"image":{"@id":"https:\/\/genepredictis.com\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/genepredictis.com\/fr\/#\/schema\/person\/b71b43f714d8b16c629df67fbcc28171","name":"masmo","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/57bae57399cbed2da108452f7dd7e0b5394fa18315d8e0a8141267734d649b82?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/57bae57399cbed2da108452f7dd7e0b5394fa18315d8e0a8141267734d649b82?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/57bae57399cbed2da108452f7dd7e0b5394fa18315d8e0a8141267734d649b82?s=96&d=mm&r=g","caption":"masmo"},"url":"https:\/\/genepredictis.com\/fr\/author\/masmo\/"}]}},"_links":{"self":[{"href":"https:\/\/genepredictis.com\/fr\/wp-json\/wp\/v2\/posts\/4221","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/genepredictis.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/genepredictis.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/genepredictis.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/genepredictis.com\/fr\/wp-json\/wp\/v2\/comments?post=4221"}],"version-history":[{"count":4,"href":"https:\/\/genepredictis.com\/fr\/wp-json\/wp\/v2\/posts\/4221\/revisions"}],"predecessor-version":[{"id":4813,"href":"https:\/\/genepredictis.com\/fr\/wp-json\/wp\/v2\/posts\/4221\/revisions\/4813"}],"wp:attachment":[{"href":"https:\/\/genepredictis.com\/fr\/wp-json\/wp\/v2\/media?parent=4221"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/genepredictis.com\/fr\/wp-json\/wp\/v2\/categories?post=4221"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/genepredictis.com\/fr\/wp-json\/wp\/v2\/tags?post=4221"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}